# Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

> **NCT04597775** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Regional Center for Disease Control and Prevention, Jordan** · enrollment: 93 (estimated)

## Conditions studied

- SARS-CoV Infection

## Interventions

- **DRUG:** hydroxychloroquine

## Key facts

- **NCT ID:** NCT04597775
- **Lead sponsor:** Regional Center for Disease Control and Prevention, Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-27
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-01-31
- **Target enrollment:** 93 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597775, "Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04597775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*